333 related articles for article (PubMed ID: 7602798)
1. [Immunological investigations on pathogenesis of staphylococcal scalded skin syndrome].
Machida K
Rinsho Byori; 1995 Jun; 43(6):547-56. PubMed ID: 7602798
[TBL] [Abstract][Full Text] [Related]
2. Clinical manifestations of staphylococcal scalded-skin syndrome depend on serotypes of exfoliative toxins.
Yamasaki O; Yamaguchi T; Sugai M; Chapuis-Cellier C; Arnaud F; Vandenesch F; Etienne J; Lina G
J Clin Microbiol; 2005 Apr; 43(4):1890-3. PubMed ID: 15815014
[TBL] [Abstract][Full Text] [Related]
3. Relationship between susceptibility and immune response to staphylococcal exfoliative toxin A in mammalian species.
Machida K; Sakurai S; Kondo I; Ikawa S
Microbiol Immunol; 1988; 32(10):1079-84. PubMed ID: 3231130
[TBL] [Abstract][Full Text] [Related]
4. Producibility of exfoliative toxin and staphylococcal coagulase types of Staphylococcus aureus strains isolated from skin infections and atopic dermatitis.
Kanzaki H; Ueda M; Morishita Y; Akiyama H; Arata J; Kanzaki S
Dermatology; 1997; 195(1):6-9. PubMed ID: 9267729
[TBL] [Abstract][Full Text] [Related]
5. Epidemiological data of staphylococcal scalded skin syndrome in France from 1997 to 2007 and microbiological characteristics of Staphylococcus aureus associated strains.
Lamand V; Dauwalder O; Tristan A; Casalegno JS; Meugnier H; Bes M; Dumitrescu O; Croze M; Vandenesch F; Etienne J; Lina G
Clin Microbiol Infect; 2012 Dec; 18(12):E514-21. PubMed ID: 23078129
[TBL] [Abstract][Full Text] [Related]
6. Genetic control of immune response to staphylococcal exfoliative toxin A in mice.
Machida K; Sakurai S; Kondo I; Ikawa S
Infect Immun; 1987 Nov; 55(11):2768-73. PubMed ID: 3117691
[TBL] [Abstract][Full Text] [Related]
7. Exfoliative toxin A staphylococcal scalded skin syndrome in preterm infants.
Saida K; Kawasaki K; Hirabayashi K; Akazawa Y; Kubota S; Kasuga E; Kusakari M; Ishida T; Kitamura M; Baba A; Koike K
Eur J Pediatr; 2015 Apr; 174(4):551-5. PubMed ID: 25194957
[TBL] [Abstract][Full Text] [Related]
8. Staphylococcal scalded skin syndrome.
Gemmell CG
J Med Microbiol; 1995 Nov; 43(5):318-27. PubMed ID: 7562995
[TBL] [Abstract][Full Text] [Related]
9. Nosocomial scalded skin syndrome. Ritter's disease caused by phage group 3 Staphylococcus aureus.
Florman AL; Holzman RS
Am J Dis Child; 1980 Nov; 134(11):1043-5. PubMed ID: 6449146
[TBL] [Abstract][Full Text] [Related]
10. Recurrent staphylococcal scalded skin syndrome in children: report of two cases.
Machang'u RS; Mgode G; Gisakanyi N
East Afr Med J; 1997 Sep; 74(9):603-4. PubMed ID: 9487441
[TBL] [Abstract][Full Text] [Related]
11. Staphylococcal exfoliative toxins: "molecular scissors" of bacteria that attack the cutaneous defense barrier in mammals.
Nishifuji K; Sugai M; Amagai M
J Dermatol Sci; 2008 Jan; 49(1):21-31. PubMed ID: 17582744
[TBL] [Abstract][Full Text] [Related]
12. Toxin involvement in staphylococcal scalded skin syndrome.
Lina G; Gillet Y; Vandenesch F; Jones ME; Floret D; Etienne J
Clin Infect Dis; 1997 Dec; 25(6):1369-73. PubMed ID: 9431380
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of blister formation by staphylococcal toxins.
Hanakawa Y; Stanley JR
J Biochem; 2004 Dec; 136(6):747-50. PubMed ID: 15671483
[TBL] [Abstract][Full Text] [Related]
14. Toxin in bullous impetigo and staphylococcal scalded-skin syndrome targets desmoglein 1.
Amagai M; Matsuyoshi N; Wang ZH; Andl C; Stanley JR
Nat Med; 2000 Nov; 6(11):1275-7. PubMed ID: 11062541
[TBL] [Abstract][Full Text] [Related]
15. Toxin levels in serum correlate with the development of staphylococcal scalded skin syndrome in a murine model.
Plano LR; Adkins B; Woischnik M; Ewing R; Collins CM
Infect Immun; 2001 Aug; 69(8):5193-7. PubMed ID: 11447206
[TBL] [Abstract][Full Text] [Related]
16. [Neonatal staphylococcal epidermolysis due to maternal-fetal transmission].
Léauté-Labrèze C; Sarlangue J; Pedespan L; Doermann HP; Taïeb A
Ann Dermatol Venereol; 1999 Oct; 126(10):713-5. PubMed ID: 10604011
[TBL] [Abstract][Full Text] [Related]
17. Unique superantigen activity of staphylococcal exfoliative toxins.
Monday SR; Vath GM; Ferens WA; Deobald C; Rago JV; Gahr PJ; Monie DD; Iandolo JJ; Chapes SK; Davis WC; Ohlendorf DH; Schlievert PM; Bohach GA
J Immunol; 1999 Apr; 162(8):4550-9. PubMed ID: 10201994
[TBL] [Abstract][Full Text] [Related]
18. Distribution of the exfoliative toxin D gene in clinical Staphylococcus aureus isolates in France.
Yamasaki O; Tristan A; Yamaguchi T; Sugai M; Lina G; Bes M; Vandenesch F; Etienne J
Clin Microbiol Infect; 2006 Jun; 12(6):585-8. PubMed ID: 16700711
[TBL] [Abstract][Full Text] [Related]
19. Staphylococcal scalded skin syndrome. II. Serum level of anti exfoliatin and anti alpha-toxin in patients with staphylococcal scalded skin syndrome or bullous impetigo.
Nishioka K; Nakano T; Hirao N; Teranishi H; Asada Y
J Dermatol; 1977 Apr; 4(2):65-8. PubMed ID: 15461328
[TBL] [Abstract][Full Text] [Related]
20. Clonal association of Staphylococcus aureus causing bullous impetigo and the emergence of new methicillin-resistant clonal groups in Kansai district in Japan.
Yamaguchi T; Yokota Y; Terajima J; Hayashi T; Aepfelbacher M; Ohara M; Komatsuzawa H; Watanabe H; Sugai M
J Infect Dis; 2002 May; 185(10):1511-6. PubMed ID: 11992289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
